United States: The Saga Of Patent Eligibility Of Business Methods Continues In SmartGene v. ABL

We reported in the last edition that the U.S. Supreme Court had agreed to consider the case of Alice Corp. Pty. Ltd. v. CLS Bank International (No. 13-298) regarding patent-eligible subject matter.  The CLS Bank decision was covered in the June 2013 edition of Full Disclosure.  Click here.  Oral arguments are scheduled for March 31, 2014, with a decision expected in the early summer.

As readers of Full Disclosure know, the en banc decision in CLS Bank International v. Alice Corp. Pty. Ltd., 717 F.3d 1269 (Fed. Cir. 2013) (en banc), failed to clarify the boundaries of patent eligibility for U.S. applicants.  If the fractured decision has any value, it is in providing interesting clues to how individual Federal Circuit judges view the question of patent eligibility.  It is hoped that when the Supreme Court opines on 35 U.S.C. § 101 this time, it will impart some predictability to the patent-eligibility analysis.

The recent decision in SmartGene, Inc. v. Advanced Biological Laboratories, SA, No. 2013-1186 (Fed. Cir. Jan. 24, 2014) (unpublished), is nonprecedential but is nevertheless interesting because the opinion was authored by Circuit Judge Richard Taranto, who joined the Federal Circuit in 2013 but did not participate in the CLS Bank decision.

Judge Taranto was joined in his opinion in SmartGene by Judges Lourie and Dyk.  Judge Lourie, joined by Judge Dyk and three other judges, wrote a concurring opinion in CLS Bank affirming the district court's holding that all claims were patent ineligible under 35 U.S.C. § 101. 

In CLS Bank, Judge Lourie evaluated Supreme Court decisions and proposed an "integrated approach" to § 101 questions based on three themes appearing in those precedents:  1) patents should not preempt fundamental tools of discovery by claiming a natural law, natural phenomenon, or abstract idea; 2) the substance of a claim is more important than its form in determining patent eligibility; and 3) courts should avoid rigid rules regarding subject-matter eligibility.  Based on these themes, Judge Lourie proposed a four-step "integrated" approach:

  1. Verify that the claim fits into one of the four statutory classes of invention (process, machine, manufacture, or composition of matter);
  2. Determine whether the claim raises § 101 abstraction concerns at all;
  3. If abstraction concerns arise, unambiguously identify the fundamental concept or abstract idea; and  
  4. After identification of the abstract idea, evaluate the remainder of the claim to determine whether it contains an "inventive concept" in the form of a "genuine human contribution" above and beyond the involved abstract idea.

Lourie then applied this approach and found all the method claims patent ineligible under § 101.  For the method claims in question, Judge Lourie found that the requirement to implement the method through a computer failed to supply an "inventive concept" because it did no more than add generic computer functionality to make the processing faster.  Judge Lourie similarly found the system claims invalid, as they only served to limit the method to a particular technological environment, which was not enough to satisfy § 101.  Judge Lourie's opinion found, at least in this case, that the method and system claims should "rise or fall" together, so that the substance of a claim controls its eligibility under § 101, rather than how artfully it was drafted.

The decision in SmartGene reveals a similar approach by Judge Taranto in holding all of the claims as patent ineligible under § 101.  Judge Taranto had no problem identifying the fundamental concept of the claims: the claims were directed to an expert system including a method and system for proposing treatment options for a patient based on a consultation of three separate databases.  The claims were written in generic terms to include "providing" patient information to a "computing device" and "generating" a ranked list of treatment options.  Judge Taranto, without formulating a specific approach, appeared to follow the same analytical framework advocated by Judge Lourie in CLS Bank.  Beginning with the question of whether SmartGene's patent contained an inventive concept, Judge Taranto noted that "[t]he claim . . . calls on a computer to do nothing that is even arguably an advance in physical implementations of routine mental information-comparison and rule-application processes.  In this context, the concern about preempting public use of certain kinds of knowledge, emphasized in Mayo, is a grave one."  SmartGene, slip op. at 9-10.  Following the Supreme Court's precedents, Judge Taranto—as did Judge Lourie in CLS Bank—found that the claims did no more than recite a "computing device," with basic functionality "to do what doctors do routinely."  Id. at 8.  Judge Taranto went on to complain that the only independent claim placed "only very broad limitations on a 'computing device'" that rendered it like a doctor's mind, and not like any specific technological implementation.  Id. at 8-9.

It is tempting to speculate what the result in CLS Bank would have been had Judge Taranto participated in the en banc decision.  It should be recalled that Judge Taranto recently joined the Federal Circuit from a private law practice, as opposed to another judicial position, so some might argue that his analyses could be more in line with Supreme Court precedent.  Ultimately, however, that would be an academic exercise, because the Supreme Court will have the next opportunity to rule on the CLS Bank matter.  However, anyone attempting to "read the tea leaves" here should remember that the Supreme Court is not predictable on this patent-eligibility issue.  One need only recall the Supreme Court's decision in Bilski v. Kappos, 561 U.S. ___, 130 S. Ct. 3218 (2010), which ushered in the current era of unpredictability following the predictable laissez-faire era following State Street Bank & Trust v. Signature Financial Group, Inc., 149 F.3d 1368 (Fed. Cir. 1998).

In order to conform to the plurality in the CLS Bank decision, patent prosecutors should draft patent specifications and claims that include both method and system claims where appropriate.  Ultimately, however, claims should be drafted to recite more than merely implementing a method through a computer, such as the ABL claims found invalid in this decision.  The claims more likely to succeed under any analysis are those that cover more than simply a process that takes place with a computer which accomplishes something that is conventionally done without a computer.  The better approach is to recite a computer-implemented method in only a portion of the claim and then recite further process steps that employ the results of the computer-implemented method to accomplish some specific, real-world task.  Of course, it is important to keep in mind the joint-infringement implications when doing so.  See a discussion on the latter here.

We invite our readership to stay tuned to Full Disclosure for analyses of CLS Bank and other Supreme Court decisions as they are handed down.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
23 Jan 2018, Conference, Bangalore, India

Finnegan is a Bronze sponsor of the 10th annual Global Intellectual Property Convention, hosted by ITAG Business Solutions.

24 Jan 2018, Conference, California, United States

Finnegan is a Crystal sponsor of the American Intellectual Property Law Association Mid-Winter Institute, supporting the IP Practice in Japan Pre-Meeting.

30 Jan 2018, Webinar, Washington, DC, United States

As part of the Intellectual Property Institute of Canada’s webinar series, Finnegan partners Andrew Holtman and Jason Stach will share their insights on how the PTAB trial process is changing and how patent owners and petitioners alike can best position themselves for success.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions